Answers are grounded in this paper and cite their sources.
Graft-Versus-Host Disease (GvHD) remains a major complication of Allogeneic Stem Cell Transplantation (alloSCT). Anti-Thymocyte Globulin (ATG), however, reduces the incidence and severity of GvHD after alloSCT. A small number of studies suggest a role for ATG in Match-Related Donor (MRD) alloSCT. The aim of this study was to assess the risk of acute and chronic GvHD, engraftment, survival, and mortality in patients who received ATG prior to MRD alloSCT.
No takes yet. Share an insight, caveat, or question.
Olga Blau (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: